DNDi Welcomes Malaysia’s Move to Secure Access to More Affordable Treatments for Hepatitis C
[Drugs for Neglected Diseases press release, Link (CC-BY-NC-SA)] Malaysia has issued a “government use” licence enabling access to more affordable versions of an expensive and patented medicine to treat hepatitis C. This landmark decision should help the more than 400,000…
